CorMedix Investors Seek First OK Of Governance Reform Deal

By Katryna Perera · January 20, 2026, 4:57 PM EST

Investors in CorMedix Inc. have told a New Jersey federal judge that company directors have agreed to implement several corporate governance reforms to resolve a consolidated shareholder derivative lawsuit accusing the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Settlement

Case Information

Case Title

IN RE CORMEDIX INC. DERIVATIVE LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Stockholders Suits

Date Filed

October 13, 2021

Recent Articles By Katryna

December 22, 2025
New Class Action Claims CIBC, RBC Rigged Quantum Shares
November 25, 2025
Acadia Healthcare Investors Seek First OK For $179M Deal
November 25, 2025
Judge Hands SEC Win In Pharma Co.'s CBD Investor Fraud Case
November 18, 2025
Perrigo Sued Over Misstatements On Infant Formula Business
November 13, 2025
2nd Circ. Revives Bright Health Investors' Pandemic Suit
October 17, 2025
Acadia Investors Score Partial Win In Fraud Class Action
September 18, 2025
Cytokinetics Investor Sues Over Heart Drug Approval Claims
September 08, 2025
FibroGen To Pay SEC $1.25M Over Drug Mistatements
September 05, 2025
Vein Tech Maker Wants Suit Over DOJ Kickback Probe Tossed
August 28, 2025
2nd Circ. Affirms Hedge Fund Win In $87M Short-Swing Suit